Japan Clinical Nutrition Market Report by Product, Route of Administration, Application, End User, and Region 2024-2032
일본의 임상 영양 시장의 시장 규모는 2023년에 19억 7,220만 달러에 달했습니다. 향후 IMARC Group은 시장이 2032년까지 34억 5,180만 달러에 달하며, 2024-2032년 5.70%의 성장률(CAGR)을 보일 것으로 예측하고 있습니다. 면역력을 높이는 대체 식품의 보급과 함께 개인의 요구에 맞춘 영양에 대한 요구가 높아지고 있는 것이 주로 시장 성장의 원동력이 되고 있습니다.
본 리포트에서 답변하는 주요 질문
- 일본의 임상 영양 시장의 지금까지 실적과 향후 실적은?
- COVID-19가 일본의 임상 영양 시장에 미친 영향은?
- 일본의 임상 영양 시장의 제품별 내역은?
- 일본의 임상 영양 시장의 투여 경로별 내역은?
- 일본의 임상 영양 시장의 용도별 내역은?
- 일본의 임상 영양 시장의 최종사용자별 내역은?
- 일본의 임상 영양 시장의 밸류체인에는 어떤 단계가 있는가?
- 일본의 임상 영양에서 주요 촉진요인과 과제는 무엇인가?
- 일본의 임상 영양 시장의 구조와 주요 기업은?
- 일본의 임상 영양 시장에서 경쟁의 정도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 개요
제4장 일본의 임상 영양 시장 : 서론
제5장 일본의 임상 영양 시장 구도
- 과거 및 현재 시장 동향(2018-2023년)
- 시장 예측(2024-2032년)
제6장 일본의 임상 영양 시장 : 제품별 내역
제7장 일본의 임상 영양 시장 : 투여 경로별 내역
제8장 일본의 임상 영양 시장 : 용도별 내역
- 암
- 영양실조
- 대사장애
- 위장 장애
- 신경질환
- 기타
제9장 일본의 임상 영양 시장 : 최종사용자별 내역
제10장 일본의 임상 영양 시장 : 경쟁 구도
- 개요
- 시장 구조
- 시장 기업 포지셔닝
- 주요 성공 전략
- 경쟁 대시보드
- 기업 평가 상한
제11장 주요 기업의 개요
제12장 일본의 임상 영양 시장 : 업계 분석
- 촉진요인·억제요인·기회
- Porter's Five Forces 분석
- 밸류체인 분석
제13장 부록
KSA
Japan clinical nutrition market size reached US$ 1,972.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,451.8 Million by 2032, exhibiting a growth rate (CAGR) of 5.70% during 2024-2032. The inflating need for personalized nutrition that can be tailored to the needs of the individual, along with the widespread adoption of immunity-boosting alternatives, is primarily driving the market growth.
Clinical nutrition is a distinct area within the field of nutrition science, concentrating on the management of diseases through the application of medical nutrition therapies. It encompasses the diagnosis and prevention of nutritional and metabolic conditions linked to chronic disorders arising from insufficient essential nutrients. Various types of clinical nutrition are available, including infant nutrition, enteral nutrition, and parenteral nutrition. In addition to this, the practice of clinical nutrition yields several advantages, such as mitigating the effects of malnutrition, improving responses to disease treatments, boosting immune levels, and enhancing digestive capabilities. Consequently, it is gaining extensive popularity across the region.
Japan Clinical Nutrition Market Trends:
The increasing prevalence of metabolic disorders, which elevate the risk of conditions like obesity, high blood pressure, and abnormal cholesterol levels, serves as a primary driver for the Japan clinical nutrition market. Furthermore, the expanding geriatric population, prone to chronic gastrointestinal ailments, fuels the demand for clinical nutrition in home healthcare settings, which is acting as another significant growth-inducing factor. Apart from this, the rising number of preterm births, coupled with the growing need for clinical nutrition in pediatric medicine, contributes significantly to market growth. Continuous advancements in healthcare infrastructure and government awareness programs promoting the accessibility of clinical nutrition for disease management are key factors in this expansion. Additionally, there has been a notable surge in demand for immunity-boosting alternatives, including clinical nutrition, to mitigate the risk of coronavirus infection, which is catalyzing the market growth across Japan. Besides this, clinical nutrition plays a crucial role in treating acute malnutrition, addressing protein deficiency, and enhancing immune defenses in patients, thereby augmenting the regional market. Noteworthy innovations in clinical nutrition solutions, such as optimized lipid emulsions and the introduction of liquid oral clinical nutrition formulas, are anticipated to drive the market in Japan over the forecasted period.
Japan Clinical Nutrition Market Segmentation:
Product Insights:
- Infant Nutrition
- Parental Nutrition
- Enteral Nutrition
Route of Administration Insights:
Application Insights:
- Cancer
- Malnutrition
- Metabolic Disorders
- Gastrointestinal Disorders
- Neurological Disorders
- Others
End User Insights:
- Pediatric
- Adults
- Geriatric
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan clinical nutrition market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan clinical nutrition market?
- What is the breakup of the Japan clinical nutrition market on the basis of product?
- What is the breakup of the Japan clinical nutrition market on the basis of route of administration?
- What is the breakup of the Japan clinical nutrition market on the basis of application?
- What is the breakup of the Japan clinical nutrition market on the basis of end user?
- What are the various stages in the value chain of the Japan clinical nutrition market?
- What are the key driving factors and challenges in the Japan clinical nutrition?
- What is the structure of the Japan clinical nutrition market and who are the key players?
- What is the degree of competition in the Japan clinical nutrition market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Clinical Nutrition Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Clinical Nutrition Market Landscape
- 5.1 Historical and Current Market Trends (2018-2023)
- 5.2 Market Forecast (2024-2032)
6 Japan Clinical Nutrition Market - Breakup by Product
- 6.1 Infant Nutrition
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2018-2023)
- 6.1.3 Market Forecast (2024-2032)
- 6.2 Parental Nutrition
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2018-2023)
- 6.2.3 Market Forecast (2024-2032)
- 6.3 Enteral Nutrition
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2018-2023)
- 6.3.3 Market Forecast (2024-2032)
7 Japan Clinical Nutrition Market - Breakup by Route of Administration
- 7.1 Oral
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2018-2023)
- 7.1.3 Market Forecast (2024-2032)
- 7.2 Enteral
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2018-2023)
- 7.2.3 Market Forecast (2024-2032)
- 7.3 Parenteral
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2018-2023)
- 7.3.3 Market Forecast (2024-2032)
8 Japan Clinical Nutrition Market - Breakup by Application
- 8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2018-2023)
- 8.1.3 Market Forecast (2024-2032)
- 8.2 Malnutrition
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2018-2023)
- 8.2.3 Market Forecast (2024-2032)
- 8.3 Metabolic Disorders
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2018-2023)
- 8.3.3 Market Forecast (2024-2032)
- 8.4 Gastrointestinal Disorders
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2018-2023)
- 8.4.3 Market Forecast (2024-2032)
- 8.5 Neurological Disorders
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2018-2023)
- 8.5.3 Market Forecast (2024-2032)
- 8.6 Others
- 8.6.1 Historical and Current Market Trends (2018-2023)
- 8.6.2 Market Forecast (2024-2032)
9 Japan Clinical Nutrition Market - Breakup by End User
- 9.1 Pediatric
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2018-2023)
- 9.1.3 Market Forecast (2024-2032)
- 9.2 Adults
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2018-2023)
- 9.2.3 Market Forecast (2024-2032)
- 9.3 Geriatric
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2018-2023)
- 9.3.3 Market Forecast (2024-2032)
10 Japan Clinical Nutrition Market - Competitive Landscape
- 10.1 Overview
- 10.2 Market Structure
- 10.3 Market Player Positioning
- 10.4 Top Winning Strategies
- 10.5 Competitive Dashboard
- 10.6 Company Evaluation Quadrant
11 Profiles of Key Players
- 11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
- 11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
- 11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
- 11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
- 11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events
12 Japan Clinical Nutrition Market - Industry Analysis
- 12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
- 12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
- 12.3 Value Chain Analysis
13 Appendix
